(Q77735557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Growth Hormone Secretagogues: Physiological Role and Clinical Utility (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Casanueva FF

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

Trends in Endocrinology and Metabolism

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

30-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

On the actions of the growth hormone-releasing hexapeptide, GHRP.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone-releasing peptide and its analogues Novel stimuli to growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Peptidomimetic regulation of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Central actions of peptide and non-peptide growth hormone secretagogues in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Modulation of growth hormone-releasing activity of hexarelin in man

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Absence of desensitization by hexarelin to subsequent GH releasing hormone‐mediated GH secretion in patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone-releasing peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Human fetal pituitary expresses functional growth hormone-releasing peptide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Plasma growth hormone response to growth hormone-releasing hexapeptide (GH-RP-6) in children with short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Intranasal administration of the GHRP hexarelin accelerates growth in short children

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Influence of metabolic substrates and obesity on growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Postpartum Hyperprolactinemia and Hyporesponsiveness of Growth Hormone (GH) to GH-Releasing Peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

The growth hormone deficiency syndrome in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Beneficial effects of growth hormone treatment in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

The diagnosis of growth hormone deficiency in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Ipamorelin, the first selective growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Somatotroph insulin-like growth factor-I signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Effects of growth hormone secretagogues in the transgenic growth-retarded (Tgr) rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young men.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900116-7

7 January 2021

10.1016/S1043-2760(98)00116-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10322392%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference